MICHAEL E RYTTING to Magnetic Resonance Imaging
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Magnetic Resonance Imaging.
Connection Strength
0.142
-
Phase-contrast cerebrospinal fluid flow magnetic resonance imaging in qualitative evaluation of patency of CSF flow pathways prior to infusion of chemotherapeutic and other agents into the fourth ventricle. Childs Nerv Syst. 2018 03; 34(3):481-486.
Score: 0.047
-
Acute myeloid leukaemia masquerading as a primary CNS tumour. BMJ Case Rep. 2017 Aug 11; 2017.
Score: 0.046
-
Advanced atypical teratoid/rhabdoid tumor (ATRT) treated with intensive multimodal approach shows continued response to sarcoma type salvage therapy. Pediatr Blood Cancer. 2012 May; 58(5):823-4.
Score: 0.030
-
Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial. J Neurooncol. 2015 Oct; 125(1):133-41.
Score: 0.010
-
Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus. Anticancer Res. 2014 Apr; 34(4):1939-45.
Score: 0.009